HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The treatment of refractory pneumothorax in diffuse panbronchiolitis by intravenous administration of coagulation factor XIII concentrate.

Abstract
This case report presents a patient with advanced diffuse panbronchiolitis accompanied by chronic respiratory failure, marked cachexia, and refractory spontaneous pneumothorax. Because instillation of a pleurodesis agent and thoracoscopy were considered highly risky and invasive, we instead treated the patient with intravenous administration of a coagulation factor XIII concentrate, and the pneumothorax resolved. This case suggests refractory pneumothorax in a restrictive ventilatory disorder can be effectively treated with noninvasive intravenous administration of coagulation factor XIII concentrate.
AuthorsAkira Murata, Ayumi Kouno, Kazuo Yamamoto, Hiroko Yoshioka, Kozui Kida, Shoji Kudoh
JournalJournal of Nippon Medical School = Nippon Ika Daigaku zasshi (J Nippon Med Sch) Vol. 73 Issue 2 Pg. 89-92 (Apr 2006) ISSN: 1345-4676 [Print] Japan
PMID16641533 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Factor XIII
Topics
  • Bronchiolitis (complications)
  • Factor XIII (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Injections, Intravenous
  • Middle Aged
  • Pneumothorax (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: